Medical Therapeutics

YourChoice Therapeutics

Brief Description

YourChoice Therapeutics is revolutionizing birth control options for women and men by developing hormone-free contraceptives and bringing them to market. Our technology is the result of a decade of research at the University of California, Berkeley and has been published in numerous high-impact journals.

Timeline 2018. Company founded Inventors

Yuriy Kirichok, Polina Lishko, Nadja Mannowetz, Melissa Miller

Ogma Scientific

Brief Description

Ogma Scientific works with clients in the energy, mining and agriculture sectors and clients in the chemical industry to identify innovative treatment strategies for problems in industrial ecosystems. Our high-throughput screening services are uniquely tailored to identify successful treatments to stop undesirable microbial activity that impacts industrial processes. Examples include biosouring in the oil sector and acid mine drainage in the mining sector. Biosouring alone, caused by the inadvertent stimulation of microbial activity during oil or gas recovery, costs the...

Scribe Therapeutics

Brief Description

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders. The molecular engineering company was spun out of discoveries in the lab of UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology and Nobel Laureate Jennifer Doudna. Doudna co-founded Scribe with company CEO Benjamin Oakes, who received a PhD in Molecular and Cellular Biology from UC Berkeley in 2017, where he worked in the Doudna Lab and Savage Lab, UC Berkeley Associate Professor of...

Iaterion

Brief Description

Iaterion is a biopharma company developing novel therapeutics for women's health and diseases. The company develops targeted selective nuclear receptor drugs addressing multiple indications encountered by women and focuses on novel drugs as an alternative to menopausal hormone therapy (MHT). The company was founded to commercialize a novel discovery made by UC Berkeley Adjunct Professor in the Department of Nutritional Sciences Dale Leitman, MD, PhD, for nuclear receptors reprogramming (NRRP) agents.

Iaterion's team brings decades of experience in the bio-...

GenEdit, Inc.

Brief Description

GenEdit develops innovative therapies through targeted delivery of genetic medicines. The GenEdit founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.

The company's proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of CRISPR ribonucleoprotein (RNP...

Redwood Bioscience Inc.

Brief Description

Redwood Bioscience, Inc. develops a protein-chemical engineering technology to produce antibody-drug conjugates and other semi-synthetic biotherapeutics. The company offers SMARTag site-specific protein modification and cytotoxin-linker technologies that enable the generation of homogenous bioconjugates engineered to enhance potency, safety, and stability. Its SMARTag platform provides precise payload positioning and defined stoichiometry of payload-protein ratios. The company was incorporated in 2008 and is based in Emeryville, California. Redwood Bioscience, Inc....

Protiveris, Inc.

Brief Description

Protiveris Inc. develops and commercializes micro- and nanocantilever systems for academic research, drug discovery and development, bio-defense, protein research, and discovery of new pharmaceuticals and diagnostic applications.

Timeline 1998. Company founded Inventors

Ohmyyoung Kwon, Arunava Majumdar, Minyao Mao, Thomas Perazzo, Guanghua Wu, Yang Zhao

Prolific Machines

Brief Description

Prolific Machines specializes in cell production with a unique manufacturing approach that combats climate change, enables space-food, and makes cell therapy accessible to everyone. The company's photomolecular biology platform leverages safe and effective tools — light, bioengineering, hardware, and AI — for dynamic control over virtually any cell function in any cell type. With the technology, partners can more efficiently biomanufacture nutritional proteins, antibodies to treat diseases, cultivated meat, and more.

Timeline 2020. Company founded...

Omniox, Inc.

Brief Description

Omniox is an early stage biopharmaceutical company developing new medicines for hypoxic diseases. Hypoxia (oxygen deficiency) impacts cancer, cardiovascular diseases, trauma and many other conditions. The company has engineered an unusually stable oxygen carrier technology (H-NOX) to deliver oxygen into hypoxic tissues and improve the treatment of severe unmet medical needs. The technology overcomes the modes of failure of prior efforts in the field of oxygen therapeutics.

Timeline 2006. Company founded. Inventors

Elizabeth Boon,...

Mammoth Biosciences

Brief Description

Mammoth’s vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners - democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.

Timeline 2017. Company founded Inventors

Jennifer Doudna, Alexandra Seletsky, Amanda Mok, Brittney Wai-Li Thornton, David Frank Savage, Dylan Smock, Eli Dugan, Emeric Jean Charles, Gavin Knott, James Doudna Cate, John Desmarais, Liana Lareau,...